News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
506,745 Results
Type
Article (12036)
Company Profile (144)
Press Release (494797)
Multimedia
Podcasts (14)
Webinars (6)
Section
Business (170912)
Career Advice (443)
Deals (26393)
Drug Delivery (19)
Drug Development (55275)
Employer Resources (26)
FDA (10497)
Job Trends (8999)
News (245769)
Policy (19079)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (787)
Accelerated approval (30)
ADA (20)
Adcomms (2)
Allergies (101)
Alliances (34102)
ALS (157)
Alzheimer's disease (1096)
Antibody-drug conjugate (ADC) (309)
Approvals (11177)
Artificial intelligence (371)
ASCO (169)
Autoimmune disease (241)
Automation (30)
Bankruptcy (274)
Belgium (3)
Best Places to Work (7276)
BIO (36)
Biologics (11)
BIOSECURE Act (2)
Biosimilars (125)
BioSpace Insights (26)
Biotechnology (94)
Bispecific (3)
Bladder cancer (160)
Brain cancer (38)
Breast cancer (527)
Cancer (4008)
Cardiovascular disease (247)
Career advice (369)
Career pathing (2)
CAR-T (197)
CDC (7)
CDMO (33)
Celiac Disease (1)
Cell therapy (529)
Cervical cancer (37)
Clinical research (50082)
Collaboration (1362)
Commercialization (3)
Company closure (1)
Compensation (1546)
Complete response letters (43)
COVID-19 (961)
CRISPR (74)
C-suite (863)
Cystic fibrosis (93)
Data (6234)
Denatured (8)
Depression (118)
Dermatology (80)
Diabetes (398)
Diagnostics (4512)
Digital health (40)
Diversity (1)
Diversity, equity & inclusion (9)
Drug discovery (180)
Drug pricing (24)
Drug shortages (5)
Duchenne muscular dystrophy (177)
Earnings (75116)
Editorial (10)
Employer branding (3)
Employer resources (25)
Events (90724)
Executive appointments (750)
FDA (13436)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (20)
Frontotemporal dementia (28)
Funding (1027)
Gene editing (142)
Generative AI (16)
Gene therapy (384)
GLP-1 (363)
Government (1246)
Grass and pollen (2)
Guidances (301)
Healthcare (10059)
Hematology (97)
HIV (55)
Huntington's disease (34)
IgA nephropathy (75)
Immunology and inflammation (116)
Immuno-oncology (69)
Indications (174)
Infectious disease (1163)
Inflammatory bowel disease (134)
Inflation Reduction Act (4)
Influenza (86)
Intellectual property (271)
Interviews (73)
IPO (12700)
IRA (6)
Job creations (2079)
Job search strategy (324)
JPM (6)
Kidney cancer (18)
Kidney disease (48)
Labor market (3)
Layoffs (94)
Leadership (7)
Legal (5384)
Licensing (22)
Liver cancer (49)
Longevity (22)
Lung cancer (583)
Lymphoma (284)
Machine learning (32)
Management (7)
Manufacturing (627)
Marketing (8)
MASH (125)
Medical affairs (2)
Medical device (9164)
Medtech (9333)
Mergers & acquisitions (14780)
Metabolic disorders (839)
mRNA (79)
Multiple sclerosis (121)
Multispecific (1)
NASH (4)
Netherlands (5)
Neurodegenerative disease (272)
Neuropsychiatric disorders (50)
Neuroscience (2116)
NextGen: Class of 2026 (3350)
Non-profit (1133)
Now hiring (1)
Obesity (290)
Opinion (43)
Ovarian cancer (169)
Pain (186)
Pancreatic cancer (218)
Parkinson's disease (235)
Partnered (13)
Patents (523)
Patient recruitment (550)
Patient selection (12)
Peanut (32)
People (42536)
Peptides (4)
Pharmaceutical (31)
Pharmacy benefit managers (11)
Phase 1 (16085)
Phase 2 (22244)
Phase 3 (15424)
Pipeline (8242)
Policy (39)
Postmarket research (1633)
Preclinical (6848)
Press Release (36)
Prostate cancer (201)
Psychedelics (16)
Radiopharmaceuticals (199)
Rare diseases (661)
Real estate (3239)
Recruiting (10)
Regenerative medicine (5)
Regulatory (16033)
Reports (27)
Research institute (763)
Resumes & cover letters (72)
Rett syndrome (43)
RNA editing (6)
RSV (50)
Schizophrenia (110)
Series A (174)
Series B (135)
Service/supplier (5)
Sickle cell disease (70)
Special edition (2)
Spinal muscular atrophy (94)
Sponsored (10)
Startups (2117)
Stomach cancer (3)
Substance use disorders (17)
Supply chain (56)
Tariffs (7)
The Weekly (6)
Vaccines (415)
Venture capital (26)
Weight loss (119)
Women's health (98)
Worklife (2)
Date
Today (86)
Last 7 days (322)
Last 30 days (1618)
Last 365 days (19928)
2026 (14761)
2025 (19972)
2024 (23838)
2023 (27618)
2022 (35983)
2021 (38685)
2020 (35171)
2019 (24888)
2018 (18725)
2017 (19762)
2016 (19060)
2015 (25503)
2014 (22536)
2013 (18896)
2012 (20992)
2011 (21292)
2010 (20976)
Location
Africa (271)
Alabama (80)
Alaska (2)
Arizona (322)
Arkansas (11)
Asia (20141)
Australia (2349)
California (12709)
Canada (3364)
China (679)
Colorado (509)
Connecticut (442)
Delaware (233)
Europe (29254)
Florida (1912)
Georgia (399)
Hawaii (3)
Idaho (46)
Illinois (780)
India (59)
Indiana (373)
Iowa (16)
Japan (465)
Kansas (106)
Kentucky (32)
Louisiana (28)
Maine (26)
Maryland (1250)
Massachusetts (8371)
Michigan (316)
Minnesota (583)
Mississippi (4)
Missouri (94)
Montana (20)
Nebraska (11)
Nevada (125)
New Hampshire (65)
New Jersey (2843)
New Mexico (12)
New York (2999)
North Carolina (1344)
North Dakota (5)
Northern California (6434)
Ohio (305)
Oklahoma (14)
Oregon (16)
Pennsylvania (2349)
Puerto Rico (24)
Rhode Island (30)
South America (464)
South Carolina (78)
South Dakota (1)
Southern California (5249)
Tennessee (128)
Texas (2060)
United States (41345)
Utah (379)
Vermont (2)
Virginia (167)
Washington D.C. (40)
Washington State (973)
West Virginia (1)
Wisconsin (79)
Wyoming (2)
506,745 Results for "berkeley lights inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley
September 21, 2026
·
3 min read
Press Releases
Light-Activated Ruvidar and Interferon Demonstrate Enhanced Efficacy
Theralase(R) Demonstrates Additive Anti-Cancer Effect in Bladder Cancer In-Vitro Model when Light-Activated Ruvidar(R) is Combined with Interferon
March 2, 2026
·
6 min read
IPO
Electra lights up with $350M IPO for pivotal immune-disease drug development
Electra Therapeutics has exceeded its initial fundraising plans as it becomes the 26th biotech to debut publicly this year and outlines pivotal development plans for its monoclonal antibody ipsoprubart.
September 18, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Blood Cancer United Launches 2026 Light The Night Season During Blood Cancer Awareness Month
August 25, 2026
·
2 min read
Press Releases
Biofrontera Announces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma
September 14, 2026
·
8 min read
Press Releases
Avulux Granted FDA De Novo Authorization, Creating the First Lens Classification for Migraine-Associated Light Sensitivity
August 24, 2026
·
6 min read
Press Releases
Illumisoft Lighting Corp. Provides Corporate Update Following Commencement of Trading
May 5, 2026
·
14 min read
AbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights’ Request for Rehearing
AbCellera (Nasdaq: ABCL) announced that the United States Patent and Trademark Office’s (USPTO) Patent Trial and Appeal Board (PTAB) has denied a rehearing request in an Inter Partes Review (IPR) filed by Berkeley Lights, Inc. (Berkeley Lights) that challenged AbCellera’s U.S. Patent No. 10,087,408 (the ‘408 Patent).
July 24, 2023
·
4 min read
Deals
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
Berkeley Lights and IsoPlexis announced a definitive agreement under which Berkeley Lights will acquire IsoPlexis in an all-stock transaction valued at $57.8 million.
December 21, 2022
·
14 min read
Business
Berkeley Lights Reports Third Quarter 2022 Financial Results
Berkeley Lights, Inc., a leader in digital cell biology, reported financial results for the quarter ended September 30, 2022.
November 8, 2022
·
7 min read
1 of 50,675
Next
